84 related articles for article (PubMed ID: 4242310)
1. Antitumor factors of draining lymph node cells of the mouse sensitized with ehrlich ascites tumor cells. I. Antitumor effect of subcellular factor.
Nakashima Y
Acta Med Okayama (1952); 1969 Apr; 23(2):95-104. PubMed ID: 4242310
[No Abstract] [Full Text] [Related]
2. Antitumor factors of regional lymph node cells in the transplantation of Ehrlich ascites tumor cells. II. Properties of antitumor factors.
Nakashima Y
Acta Med Okayama (1952); 1969 Jun; 23(3):219-26. PubMed ID: 4242843
[No Abstract] [Full Text] [Related]
3. Antitumor factor of regional lymph node cells in the transplantation of Ehrlich tumor cells. 3. Passive transfer of the antitumor factor.
Nakashima Y
Acta Med Okayama (1952); 1969 Aug; 23(4):283-90. PubMed ID: 4243561
[No Abstract] [Full Text] [Related]
4. Action mechanism in vitro of sensitized regional lymph node cells on target cell. II. Difference in the biological effect of regional lymph node cells of Ehrlich cancer transplanted mouse and that of normal lymph node cells induced by PHA, on Ehrlich cancer cell line (JTC-11 cell).
Konaga E
Acta Med Okayama (1952); 1972 Aug; 26(3):99-117. PubMed ID: 4268713
[No Abstract] [Full Text] [Related]
5. Action mechanism in vitro of sensitized regional lymph node cells on target cell. I. Anti-growth effect of regional lymph node cells of Ehrlich cancer transplanted mouse and that of normal lymph node cells induced by PHA, on Ehrlich cancer cell line (JTC-11).
Konaga E
Acta Med Okayama (1952); 1971 Aug; 25(4):269-85. PubMed ID: 4263561
[No Abstract] [Full Text] [Related]
6. A study on transplantation immunity of Ehrlich ascites tumor and methylcholanthrene-induced tumor in mice, with special reference to local immunity of lymph nodes draining the site of sensitization.
Kitano M; Okada Y
Bull Chest Dis Res Inst Kyoto Univ; 1968 Mar; 1(1):1-17. PubMed ID: 5678190
[No Abstract] [Full Text] [Related]
7. The theta antigenicity of lymphoid organs of mice bearing the Ehrlich ascites tumor.
Loring M; Schlesinger M
Cancer Res; 1970 Aug; 30(8):2204-7. PubMed ID: 5466693
[No Abstract] [Full Text] [Related]
8. Antibody formation for malignant tumor. I. Antitumor activity of the regional lymph node protein.
Yamamoto Y; Nakashima Y; Okano Y
Gan; 1968 Apr; 59(2):109-16. PubMed ID: 5723055
[No Abstract] [Full Text] [Related]
9. Tumor inhibition by means of sensitized regional lymph nodes.
Arlen M; Forte RA; Levowitz BS; Scherrer J; Hodenberg M
Surg Forum; 1969; 20():114-5. PubMed ID: 5383023
[No Abstract] [Full Text] [Related]
10. Time-lapse changes in the concomitant immunity of lymphoid cells from different regions of Ehrlich tumor-bearing mice and alterations in blastformation rate by PHA-stimulation.
Orita K; Tomoyasu S; Kaneda S; Miwa H; Konaga E
Acta Med Okayama (1952); 1972 Aug; 26(3):81-8. PubMed ID: 4268711
[No Abstract] [Full Text] [Related]
11. [Studies on immune response of experimental tumors--observations on the immune response of lymph nodes of mice bearing implanted Ehrlich ascitic tumor or sarcoma 180 (author's transl)].
Chen QF; Zhou SL; Liu QR
Zhonghua Zhong Liu Za Zhi; 1980 Sep; 2(3):193-6. PubMed ID: 7227183
[No Abstract] [Full Text] [Related]
12. [Influence of immunological factors on the antitumor action of 4-diphenylylglioxal in Ehrlich ascites cancer].
Melan F; Testorelli C
Arch Ital Patol Clin Tumori; 1969; 12(1):57-67. PubMed ID: 5396284
[No Abstract] [Full Text] [Related]
13. Cellular antibody in mice bearing Ehrlich cancer. II. Properties of lymphoid cells from sensitized animal.
Hara S
Acta Med Okayama (1952); 1965 Apr; 19(2):99-106. PubMed ID: 4221944
[No Abstract] [Full Text] [Related]
14. Mechanisms of the potentiation of specific antitumor immunity by intratumor injection of Corynebacterium parvum.
Miyata H; Himeno K; Nomoto K
Cancer Res; 1983 Oct; 43(10):4670-5. PubMed ID: 6883325
[TBL] [Abstract][Full Text] [Related]
15. Successful adoptive immunotherapy of murine poorly immunogenic tumor with specific effector cells generated from gene-modified tumor-primed lymph node cells.
Tanaka H; Yoshizawa H; Yamaguchi Y; Ito K; Kagamu H; Suzuki E; Gejyo F; Hamada H; Arakawa M
J Immunol; 1999 Mar; 162(6):3574-82. PubMed ID: 10092816
[TBL] [Abstract][Full Text] [Related]
16. [The reactivity of the regional lymph nodes and tumor stroma in cervix uteri cancer].
Raĭchev I; Raĭchev S
Akush Ginekol (Sofiia); 1993; 32(1):25-8. PubMed ID: 8172342
[TBL] [Abstract][Full Text] [Related]
17. Cellular antibody in mice bearing Ehrlich cancer. I. A quantitative study on antitumor activity of cellular antibody in vitro.
Hara S
Acta Med Okayama (1952); 1965 Apr; 19(2):91-8. PubMed ID: 4221891
[No Abstract] [Full Text] [Related]
18. Studies on the tumor-host relationship. II. Serum resistant factor(s) produced by tumor transplantation.
Tanino T
Jpn J Exp Med; 1968 Oct; 38(5):383-92. PubMed ID: 5305973
[No Abstract] [Full Text] [Related]
19. Characteristics and in vivo homing of long-term T-cell lines and clones derived from tumor-draining lymph nodes.
Matsumura T; Sussman JJ; Krinock RA; Chang AE; Shu S
Cancer Res; 1994 May; 54(10):2744-50. PubMed ID: 8168105
[TBL] [Abstract][Full Text] [Related]
20. Antitumor effect of lymphocyte and macrophage from mice immunized with Ehrlich ascites tumor cells.
Sakashita T
Mie Med J; 1971 Jan; 20(3):227-41. PubMed ID: 5558109
[No Abstract] [Full Text] [Related]
[Next] [New Search]
